In the Press
June 16, 2020

Biotech Investor RA Capital Makes Strong Case for New SPAC (The Deal)

Biotech investor RA Capital Management LLP has registered a special purpose acquisition vehicle, Therapeutics Acquisition Corp., to raise $115 million. The SPAC is represented by Technology lawyers Jocelyn Arel and Daniel Espinoza of Goodwin. Read The Deal article here